4'-((N-Methylpentanamido)methyl)-[1,1'-biphenyl]-2-carboxylic Acid

ID: ALA4751424

PubChem CID: 162651170

Max Phase: Preclinical

Molecular Formula: C20H23NO3

Molecular Weight: 325.41

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC(=O)N(C)Cc1ccc(-c2ccccc2C(=O)O)cc1

Standard InChI:  InChI=1S/C20H23NO3/c1-3-4-9-19(22)21(2)14-15-10-12-16(13-11-15)17-7-5-6-8-18(17)20(23)24/h5-8,10-13H,3-4,9,14H2,1-2H3,(H,23,24)

Standard InChI Key:  DGBCZLNKIZJEPQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
   12.5891  -10.0049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2941   -9.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0032  -10.0049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0032  -10.8221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2941  -11.2307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5891  -10.8221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8800   -9.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1709  -10.0049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4660   -9.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4660   -8.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1709   -8.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8800   -8.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2941   -8.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5891   -8.3664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0032   -8.3664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7569   -8.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3428   -8.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6338   -8.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9247   -8.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2197   -8.7791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5106   -8.3664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3428   -7.5492    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0478   -8.7791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0478   -9.5963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
  1  7  1  0
 13 14  2  0
 13 15  1  0
  2 13  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 17 22  2  0
 17 23  1  0
 23 24  1  0
 16 23  1  0
 10 16  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4751424

    ---

Associated Targets(Human)

LTB4R2 Tchem Leukotriene B4 receptor 2 (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LTB4R Tchem Leukotriene B4 receptor 1 (1083 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 325.41Molecular Weight (Monoisotopic): 325.1678AlogP: 4.20#Rotatable Bonds: 7
Polar Surface Area: 57.61Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.68CX Basic pKa: CX LogP: 4.04CX LogD: 0.72
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.83Np Likeness Score: -0.89

References

1. Hernandez-Olmos V,Heering J,Planz V,Liu T,Kaps A,Rajkumar R,Gramzow M,Kaiser A,Schubert-Zsilavecz M,Parnham MJ,Windbergs M,Steinhilber D,Proschak E.  (2020)  First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters.,  63  (20): [PMID:32946232] [10.1021/acs.jmedchem.0c00588]
2. Yokomizo, T T, Kato, K K, Terawaki, K K, Izumi, T T and Shimizu, T T.  2000-08-07  A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.  [PMID:10934230]
3. Iizuka, Yoshiko Y and 5 more authors.  2005-07-01  Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes.  [PMID:15866883]
4. Okuno, Toshiaki and 5 more authors.  2008-04-14  12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2.  [PMID:18378794]

Source